Aurora Cannabis (TSE:ACB) Sets New 12-Month High at $6.53


Aurora Cannabis Inc. (TSE:ACB – Get Free Report)’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as C$6.53 and last traded at C$6.42, with a volume of 3144037 shares. The stock had previously closed at C$5.19.

Wall Street Analyst Weigh In

ACB has been the topic of several analyst reports. Jefferies Financial Group cut their price target on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. CIBC cut their price target on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. Finally, Canaccord Genuity Group raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price target on the stock in a research report on Friday, February 9th.

Get Our Latest Stock Report on ACB

Aurora Cannabis Stock Up 27.2 %

The company has a market capitalization of C$359.96 million, a price-to-earnings ratio of -0.08 and a beta of 2.83. The firm’s 50 day moving average price is C$2.43 and its two-hundred day moving average price is C$1.32. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51.

Aurora Cannabis (TSE:ACB – Get Free Report) last released its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share for the quarter, missing the consensus estimate of C($0.10) by C($0.10). Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. The firm had revenue of C$72.61 million for the quarter, compared to analyst estimates of C$63.50 million. Sell-side analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

See Also



Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Be the first to comment

Leave a Reply

Your email address will not be published.


*